can be defined as inorganic or organic materials that are biocompatible
and can be implanted in the human body to replace or repair failing tissue.
The concept extends to the materials used in drug-delivery systems, biosensors
or devices operating outside the body but in communication with it - for
example, the haemodialyser for patients with kidney failure.
years, progress in many different fields has paved the way to creating
innovative biomaterials to improve existing treatments and develop new
ones for a higher quality of life for European citizens. Both public health
and the European economy stand to gain. This explains why research programmes
sponsored by the European Commission (EC) include biomaterials research.
also include: vascular graft materials; dental and ocular materials; cartilage,
joint, tendon, ligament and soft tissue replacements; modulation of hair
follicle growth; biomaterials with improved resistance to infection; and
bio-active coatings for biomaterials and drug-delivery systems.